Schwarzenböck Sarah M, Garibotto Valentina
Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.
Diagnostic Department, University Hospitals of Geneva, NIMTLab, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1808-1819. doi: 10.1007/s00259-020-04833-8. Epub 2020 May 15.
The 32th Annual Congress of the European Association of Nuclear Medicine (EANM) returned to Barcelona, Spain, from the 12th to the 16th of October 2019, under the chairmanship of Professor Francesco Giammarile. With a total number of 6833 participants from all over the world, the EANM congress was the year's most important meeting in nuclear medicine worldwide. The congress was an unprecedented success, with more than 1800 submitted abstracts presented in scientific sessions and a variety of lectures including CME sessions from all fields of nuclear medicine and multidisciplinary joint symposia with clinical societies. Innovative research was presented in all fields, showing important developments in radiopharmacy and preclinical oncology, PET and non-PET diagnostic strategies, new therapeutic approaches and molecular imaging-based prediction of prognosis and treatment response. In the field of physics and instrumentation, technological progresses, radiomics and artificial intelligence were highlighted as most relevant areas of innovation. This review gives a summary of our personal choice among the most notable developments of this year's contributions as presented in the Highlights session of the Annual congress of the EANM 2019. EANM 2019 outlines a bright future for nuclear medicine, with groups competing all over the world to bring innovation across all fields of medicine, through increased standardization, progressively lower radiation dose and increasingly high clinical impact.
第32届欧洲核医学协会（EANM）年会于2019年10月12日至16日在西班牙巴塞罗那举行，由弗朗切斯科·贾马里莱教授担任主席。来自世界各地的6833名参会者齐聚一堂，此次EANM大会是当年全球核医学领域最重要的会议。大会取得了空前的成功，在科学会议上展示了1800多篇提交的摘要，并举办了各种讲座，包括核医学各个领域的继续医学教育课程以及与临床学会的多学科联合研讨会。各个领域都展示了创新性研究，显示出放射性药物学和临床前肿瘤学、PET和非PET诊断策略、新治疗方法以及基于分子成像的预后和治疗反应预测等方面的重要进展。在物理和仪器领域，技术进步、放射组学和人工智能被视为最相关的创新领域。本综述总结了我们在2019年EANM年会亮点环节中所展示的本年度最显著进展中个人的选择。EANM 2019为核医学勾勒了光明的未来，世界各地的团队竞相通过提高标准化、逐步降低辐射剂量以及日益增强的临床影响力，在医学各个领域带来创新。
